Research presented at the European Association for the Study of Diabetes annual meeting in Milan shows that AI-based analysis of voice patterns can detect signs of type 2 diabetes from just 20 seconds of speech. The study represents the largest research of its kind examining vocal biomarkers for diabetes screening.
Analysis of more than 57,000 UK Biobank participants found that greater variation in blood pressure measurements between research visits was associated with increased risk of death, with some blood pressure measures also linked to stroke risk. The findings were presented at the European Association for the Study of Diabetes annual meeting.
Medical experts are sequencing plasma p-tau217 and beta-amyloid 42/40 testing alongside cognitive screening as first-line diagnostic tools for Alzheimer's disease, reserving confirmatory amyloid PET or CSF testing for inconclusive cases. Payer coverage for these biomarker tests has expanded, marking a shift in the diagnostic toolkit.
Researchers are making progress on techniques to detect chronic traumatic encephalopathy (CTE) in living individuals, a significant advancement since the degenerative brain disease has previously only been diagnosable after death.
Scientists have identified a persistent molecular warning sign in intestinal cells that remains even when inflammatory bowel disease patients are in remission. The discovery, based on analysis of approximately 900 human gut biopsies and patient-derived mini-intestines, suggests cells can retain abnormalities that may trigger disease relapse.
A prospective study of 1,785 individuals across four countries shows the PANXEON exosome-based biomarker, combined with CA 19-9 levels, achieves high sensitivity for detecting early-stage pancreatic ductal adenocarcinoma. The investigational test, developed by researchers at City of Hope, could enable detection when the disease is more treatable.
Insilico Medicine announced that rentosertib, an experimental lung disease drug developed using artificial intelligence, demonstrated the ability to reduce biological age markers in a 42-patient trial. Six independently built aging clocks all showed patients on the drug appeared biologically younger, according to a study conducted with researchers from Harvard Medical School, Stanford University, and The Broad Institute.
Rentosertib, an experimental lung disease drug developed using artificial intelligence, demonstrated the ability to reverse biological signs of aging in a study, according to its developer, suggesting broader potential applications beyond its original target condition.
The FDA has approved TAUKLARIFY (florquinitau F 18 injection), a novel diagnostic imaging agent developed by Enigma Biomedical USA to identify tau neurofibrillary tangles in patients being evaluated for Alzheimer's disease, including tangles isolated to the medial temporal lobe.
Researchers have discovered a gene that regulates when heart muscle cells stop dividing and develop the specialized characteristics needed for lifelong cardiac function, addressing a fundamental question in cardiovascular biology.
A recent clinical trial found that a single dose of ketamine increases morning cortisol levels in suicidal patients for up to 24 hours, potentially explaining the drug's rapid antidepressant and anti-suicidal effects. The finding adds to understanding of ketamine's therapeutic mechanisms beyond its original use as an anesthetic.
New research published in Neurology Open Access finds that maintaining normal blood pressure, avoiding type 2 diabetes, and not smoking between ages 45-68 is associated with nearly 13 more years of dementia-free life after age 55 compared to those with all three risk factors.
Researchers have overturned longstanding scientific dogma by discovering that beginning around age 50, the brain's memory center loses its longtime resident immune cells (microglia) and replaces them with more inflammatory immune cells derived from peripheral blood stem cells. This previously unrecognized migration may help explain how normal aging sets the stage for Alzheimer's disease and dementia.
Researchers demonstrate fingertip sensors can identify physical patterns linked to stress, anxiety and depression, while major wearable companies including Whoop, Oura, and Apple expand into healthcare applications. Amae Health partners with Google Health to integrate Fitbit and voice biomarkers for precision psychiatry.
Researchers have developed a novel artificial intelligence model that analyzes data from routine polysomnography sleep studies to identify patients' long-term health risks, including cognitive decline. The study was published in Nature Communications.
Researchers have developed an artificial intelligence foundation model that analyzes routine polysomnography data to identify patients' long-term health risks, with high-risk patients showing twice the mortality risk over five years compared to low-risk patients. The study, published in Nature Communications, demonstrates that sleep studies contain far more predictive health information than currently utilized by clinicians.
Multiple breakthrough technologies for Alzheimer's detection are emerging, including a blood test that delivers results in 18 minutes, AI analysis of brain scans requiring minimal computing power, and machine learning that identifies dementia risk through sleep EEG patterns years before symptoms appear.
New research has discovered that periodontitis reprograms bone marrow neutrophils through a Chac2-driven glutathione metabolic pathway, causing them to enter a highly inflammatory N1 state that drives systemic inflammation throughout the body.
Swiss technology innovation center CSEM and biosensing technology company B-Secur announced a partnership to integrate clinically-validated heart monitoring capabilities into health wearables, combining CSEM's PPG-based vital signs monitoring expertise with B-Secur's biosensing technology.
Penn State engineers have created temporary smart tattoos capable of monitoring brain waves and detecting heart attacks, while UC San Diego researchers developed a smart ring that tracks four biomarkers in sweat simultaneously, representing advances in real-time health monitoring technology.
Scientists at Kyushu University in Japan have identified a sulfur-based compound called LASSS that protects and enhances a key muscle-repair protein called HGF, potentially offering a way to combat the muscle deterioration that occurs with aging. The compound appears to shield the protein from age-related chemical damage and more than double its strength.
New research demonstrates that RNA-based testing can improve detection of MET exon 14 skipping mutations in lung cancer patients, while circulating tumor DNA (ctDNA) testing is increasingly being adopted for early cancer detection and treatment monitoring across oncology.
A new study demonstrates that a blood test measuring p-tau217 levels can identify healthy older adults at high risk of developing Alzheimer's symptoms within five to 10 years, potentially enabling early intervention as prevention trials advance.
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging beyond its metabolic effects.
ALZpath announced a global licensing deal with Abbott Laboratories to advance blood-based testing for Alzheimer's disease, joining the race to develop easier-to-use diagnostic options for the neurodegenerative condition.
Scientists at Oregon Health & Science University developed a new technique using electronic jolts and nanoparticles to detect pancreatic cancer from blood samples, showing promise in early trials for earlier detection of this deadly cancer.
New research using brain imaging has revealed three distinct subtypes of ADHD, each associated with different underlying brain systems, co-occurring conditions, and learning challenges. The findings suggest that inattentive and hyperactive-impulsive symptom profiles follow separate neural pathways, potentially enabling more targeted treatment interventions.
BioAge Labs announced its investigational pill for cardiovascular risk prevention significantly reduced inflammation markers in an early-stage clinical study, representing potential progress in heart disease prevention.
University of Sussex researchers, in collaboration with international scientists, identified a blood test capable of early diagnosis of the most aggressive form of brain cancer, potentially eliminating the need for dangerous surgical biopsies.
Frequent, long, or early-day naps in older adults are linked to higher mortality risk and may signal underlying conditions like cardiovascular disease, neurodegeneration, or sleep disorders, suggesting daytime sleep patterns could serve as an early warning sign of declining health.
A major study presented at ESCMID Global 2026 found that antiretroviral therapy (ART) reduces accelerated biological aging in people with HIV by nearly four years, a finding that could transform understanding of HIV treatment benefits.
International research led by RIKEN Center for Integrative Medical Sciences discovered new associations between pathogenic BRCA1 and BRCA2 gene variants and four additional cancer types beyond the previously known breast and ovarian cancers.
Scientists at the Buck Institute and UC San Francisco discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes bone quality deterioration in women, revealing an unexpected connection between neurological and skeletal health.
Research published in the Canadian Medical Association Journal found that survivors of cancer during their teen and young adult years face twice the risk of developing most types of subsequent cancers compared to the general population.
New research reveals that approximately 10% of people carry specific genetic variants that make popular diabetes and weight-loss drugs like Ozempic and Wegovy significantly less effective, providing the first genetic explanation for variable drug response.
Scientists have identified a previously unknown immune mechanism where the chloride channel PACC1 plays a crucial role in helping immune cells kill bacteria, offering a potential new therapeutic target for sepsis.
An experimental drug designed to silence a gene strongly linked to Parkinson's disease showed encouraging effects in reducing the target protein by up to 60% in a first-in-human clinical trial published in Nature Medicine.
Five years after initial lupus breakthrough, CAR-T cell therapy continues to demonstrate remissions in autoimmune diseases, generating significant research investment and experimentation beyond its original cancer applications.
A large UK trial published in the New England Journal of Medicine found that women's hormone replacement therapy patches can treat prostate cancer just as effectively as standard hormone injections but with fewer severe side effects.
A phase 1 clinical trial demonstrated that stem cell transplantation using gene-edited cells rapidly and effectively restored hemoglobin production in five patients with beta-thalassemia, allowing them to discontinue blood transfusions.
Researchers at the Terasaki Institute for Biomedical Innovation developed a smart contact lens that combines real-time intraocular pressure monitoring with responsive drug delivery for glaucoma patients, showing promise in preclinical models.
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology, and Munich Leukemia Laboratory created a data-sharing platform that unites genomics, gene expression, and clinical data for blood cancers.
Scripps Research scientists have developed a first-in-class drug compound that reduces harmful inflammation while leaving the body's ability to fight infections intact, addressing a long-sought goal in treating autoimmune diseases.
Scientists at UCLA have developed a simple and cost-effective blood test that shows promise in early studies for detecting multiple cancers, various liver conditions, and organ abnormalities from a single blood sample.
Research from the University of Oulu suggests that large variations in bedtime during midlife may double the risk of cardiovascular events, highlighting the importance of consistent sleep schedules for heart health.
New research shows that influenza vaccination significantly reduces the risk of heart attack and stroke even among people who contract the flu after vaccination, demonstrating cardiovascular benefits beyond infection prevention.
Trump administration's 2027 budget proposal calls for cutting $5 billion from the National Institutes of Health and consolidating the number of institutes and centers from 27 to 22, though Congress is unlikely to approve the cuts.
New analysis finds that exposure to chemicals used to make plastic more flexible may have contributed to approximately 1.97 million preterm births in 2018 alone, representing more than 8% of the world's total preterm births that year.
New research has established a connection between Agent Orange exposure during the Vietnam War and myelodysplastic syndrome (MDS) blood cancers, potentially enabling affected veterans to access benefits and treatment.
Multiple developments in wearable health monitoring emerged in late July 2026, including OpenAI's relaunch of ChatGPT Health with expanded U.S. access, UCSD engineers' creation of a multi-biomarker tracking ring, and Penn State's stretchable antenna technology, even as questions about device accuracy and medical reliability continue to be raised.
